+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Monkeypox Vaccine and Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report

  • 300 Pages
  • February 2024
  • Region: Global
  • Infinium Global Research
  • ID: 5944275
Description Jump to:
The report on the global monkeypox vaccine and treatment market provides qualitative and quantitative analysis for the period from 2021-2030. The global monkeypox vaccine and treatment market was valued at USD 8.19 billion in 2022 and is expected to reach USD 19.68 billion in 2030, with a CAGR of 10.14% during the forecast period 2023-2030. The study on monkeypox vaccine and treatment market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.

The monkeypox vaccine and treatment market refer to the commercial landscape associated with products and services aimed at preventing and managing monkeypox infections. This includes the development, production, and distribution of vaccines and treatments designed to mitigate the impact of monkeypox outbreaks. Companies operating in this market focus on research, manufacturing, and strategic partnerships to provide effective solutions, addressing the demand for medical interventions in regions susceptible to monkeypox infections. The market plays a crucial role in public health by offering preventive measures and therapeutic options for individuals and communities affected by monkeypox. The increasing incidence of monkeypox, accompanied by intermittent outbreaks, serves as a notable catalyst for the market. This heightened prevalence has created a demand for effective solutions and therapeutics, driving growth and innovation within the industry. As stakeholders seek to address the challenges posed by these outbreaks, opportunities for research, development, and market expansion are on the rise. The urgency to combat and manage monkeypox has propelled investment and initiatives, positioning the market to play a pivotal role in public health and safety.

The injectables segment stands out as the fastest-growing category in the monkeypox vaccine and treatment market. This notable growth is attributed to various factors such as the efficacy and rapid response associated with injectable formulations. As the demand for effective monkeypox prevention and treatment options rises, the injectables segment gains prominence due to its convenience, efficiency, and potential for widespread application. This trend underscores the increasing importance of injectable solutions in addressing the challenges posed by monkeypox, contributing significantly to the overall expansion and advancement of the market.

North America is poised to hold the most prominent market share. This prominence can be attributed to the region's robust healthcare infrastructure, advanced research capabilities, and strategic investments in the field of infectious disease management. The heightened awareness and proactive approach of North American healthcare authorities in addressing emerging health threats further contribute to this dominance. Additionally, collaborations between pharmaceutical companies, research institutions, and government agencies in North America are fostering innovation and accelerating the development of effective monkeypox vaccines and treatments. The region's pivotal market position signifies lucrative opportunities for industry players and underscores its commitment to tackling public health challenges with cutting-edge solutions.

Report Findings

1) Drivers

  • The rising prevalence of monkeypox, coupled with sporadic outbreaks, is a significant driver for the market.
  • Growing awareness and emphasis on global health security and preparedness contribute to the market's momentum.

2) Restraints

  • Stringent regulatory frameworks and meeting compliance standards can act as a barrier to market growth.

3) Opportunities

  • Increasing research and development efforts aimed at developing effective monkeypox vaccines and treatments present a significant opportunity.

Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global monkeypox vaccine and treatment market is segmented on the basis of product, gender, route of administration, and end-use.

The Global Monkeypox Vaccine and Treatment Market by Product

  • Vaccine
  • Drugs
  • Vaccinia Immune Globulin (VIG)

The Global Monkeypox Vaccine and Treatment Market by Gender

  • Male
  • Female
  • Others

The Global Monkeypox Vaccine and Treatment Market by Route of Administration

  • Oral
  • Injectables

The Global Monkeypox Vaccine and Treatment Market by End-use

  • Hospitals
  • Speciality Clinics
  • Others

Company Profiles

The companies covered in the report include
  • Bavarian Nordic
  • SIGA Technologies
  • Chimerix, Inc.
  • Piramal Pharma Solutions
  • Gilead Sciences, Inc.
  • Elabscience Biotechnology Inc.
  • Goldsite Diagnostics Inc.
  • Emergex Vaccines
  • Emergent BioSolutions
  • Emcure Pharmaceuticals

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the monkeypox vaccine and treatment market.
2. Complete coverage of all the segments in the monkeypox vaccine and treatment market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global monkeypox vaccine and treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Monkeypox Vaccine and Treatment Market Highlights
2.2. Monkeypox Vaccine and Treatment Market Projection
2.3. Monkeypox Vaccine and Treatment Market Regional Highlights
Chapter 3. Global Monkeypox Vaccine and Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Product
3.4.2. Growth Matrix Analysis by Gender
3.4.3. Growth Matrix Analysis by Route of Administration
3.4.4. Growth Matrix Analysis by End-use
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Monkeypox Vaccine and Treatment Market
Chapter 4. Monkeypox Vaccine and Treatment Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Monkeypox Vaccine and Treatment Market
5.2. Companies Profiles
5.2.1. Bavarian Nordic
5.2.2. SIGA Technologies
5.2.3. Chimerix, Inc.
5.2.4. Piramal Pharma Solutions
5.2.5. Gilead Sciences, Inc.
5.2.6. Elabscience Biotechnology Inc.
5.2.7. Goldsite Diagnostics Inc.
5.2.8. Emergex Vaccines
5.2.9. Emergent BioSolutions
5.2.10. Emcure Pharmaceuticals
Chapter 6. Global Monkeypox Vaccine and Treatment Market by Product
6.1. Vaccine
6.2. Drugs
6.3. Vaccinia Immune Globulin (VIG)
Chapter 7. Global Monkeypox Vaccine and Treatment Market by Gender
7.1. Male
7.2. Female
7.3. Others
Chapter 8. Global Monkeypox Vaccine and Treatment Market by Route of Administration
8.1. Oral
8.2. Injectables
Chapter 9. Global Monkeypox Vaccine and Treatment Market by End-use
9.1. Hospitals
9.2. Speciality Clinics
9.3. Others
Chapter 10. Global Monkeypox Vaccine and Treatment Market by Region 2023-2030
10.1. North America
10.1.1. North America Monkeypox Vaccine and Treatment Market by Product
10.1.2. North America Monkeypox Vaccine and Treatment Market by Gender
10.1.3. North America Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.4. North America Monkeypox Vaccine and Treatment Market by End-use
10.1.5. North America Monkeypox Vaccine and Treatment Market by Country
10.1.5.1. The U.S. Monkeypox Vaccine and Treatment Market
10.1.5.1.1. The U.S. Monkeypox Vaccine and Treatment Market by Product
10.1.5.1.2. The U.S. Monkeypox Vaccine and Treatment Market by Gender
10.1.5.1.3. The U.S. Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.1.4. The U.S. Monkeypox Vaccine and Treatment Market by End-use
10.1.5.2. Canada Monkeypox Vaccine and Treatment Market
10.1.5.2.1. Canada Monkeypox Vaccine and Treatment Market by Product
10.1.5.2.2. Canada Monkeypox Vaccine and Treatment Market by Gender
10.1.5.2.3. Canada Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.2.4. Canada Monkeypox Vaccine and Treatment Market by End-use
10.1.5.3. Mexico Monkeypox Vaccine and Treatment Market
10.1.5.3.1. Mexico Monkeypox Vaccine and Treatment Market by Product
10.1.5.3.2. Mexico Monkeypox Vaccine and Treatment Market by Gender
10.1.5.3.3. Mexico Monkeypox Vaccine and Treatment Market by Route of Administration
10.1.5.3.4. Mexico Monkeypox Vaccine and Treatment Market by End-use
10.2. Europe
10.2.1. Europe Monkeypox Vaccine and Treatment Market by Product
10.2.2. Europe Monkeypox Vaccine and Treatment Market by Gender
10.2.3. Europe Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.4. Europe Monkeypox Vaccine and Treatment Market by End-use
10.2.5. Europe Monkeypox Vaccine and Treatment Market by Country
10.2.5.1. Germany Monkeypox Vaccine and Treatment Market
10.2.5.1.1. Germany Monkeypox Vaccine and Treatment Market by Product
10.2.5.1.2. Germany Monkeypox Vaccine and Treatment Market by Gender
10.2.5.1.3. Germany Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.1.4. Germany Monkeypox Vaccine and Treatment Market by End-use
10.2.5.2. United Kingdom Monkeypox Vaccine and Treatment Market
10.2.5.2.1. United Kingdom Monkeypox Vaccine and Treatment Market by Product
10.2.5.2.2. United Kingdom Monkeypox Vaccine and Treatment Market by Gender
10.2.5.2.3. United Kingdom Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.2.4. United Kingdom Monkeypox Vaccine and Treatment Market by End-use
10.2.5.3. France Monkeypox Vaccine and Treatment Market
10.2.5.3.1. France Monkeypox Vaccine and Treatment Market by Product
10.2.5.3.2. France Monkeypox Vaccine and Treatment Market by Gender
10.2.5.3.3. France Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.3.4. France Monkeypox Vaccine and Treatment Market by End-use
10.2.5.4. Italy Monkeypox Vaccine and Treatment Market
10.2.5.4.1. Italy Monkeypox Vaccine and Treatment Market by Product
10.2.5.4.2. Italy Monkeypox Vaccine and Treatment Market by Gender
10.2.5.4.3. Italy Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.4.4. Italy Monkeypox Vaccine and Treatment Market by End-use
10.2.5.5. Rest of Europe Monkeypox Vaccine and Treatment Market
10.2.5.5.1. Rest of Europe Monkeypox Vaccine and Treatment Market by Product
10.2.5.5.2. Rest of Europe Monkeypox Vaccine and Treatment Market by Gender
10.2.5.5.3. Rest of Europe Monkeypox Vaccine and Treatment Market by Route of Administration
10.2.5.5.4. Rest of Europe Monkeypox Vaccine and Treatment Market by End-use
10.3. Asia Pacific
10.3.1. Asia Pacific Monkeypox Vaccine and Treatment Market by Product
10.3.2. Asia Pacific Monkeypox Vaccine and Treatment Market by Gender
10.3.3. Asia Pacific Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.4. Asia Pacific Monkeypox Vaccine and Treatment Market by End-use
10.3.5. Asia Pacific Monkeypox Vaccine and Treatment Market by Country
10.3.5.1. China Monkeypox Vaccine and Treatment Market
10.3.5.1.1. China Monkeypox Vaccine and Treatment Market by Product
10.3.5.1.2. China Monkeypox Vaccine and Treatment Market by Gender
10.3.5.1.3. China Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.1.4. China Monkeypox Vaccine and Treatment Market by End-use
10.3.5.2. Japan Monkeypox Vaccine and Treatment Market
10.3.5.2.1. Japan Monkeypox Vaccine and Treatment Market by Product
10.3.5.2.2. Japan Monkeypox Vaccine and Treatment Market by Gender
10.3.5.2.3. Japan Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.2.4. Japan Monkeypox Vaccine and Treatment Market by End-use
10.3.5.3. India Monkeypox Vaccine and Treatment Market
10.3.5.3.1. India Monkeypox Vaccine and Treatment Market by Product
10.3.5.3.2. India Monkeypox Vaccine and Treatment Market by Gender
10.3.5.3.3. India Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.3.4. India Monkeypox Vaccine and Treatment Market by End-use
10.3.5.4. South Korea Monkeypox Vaccine and Treatment Market
10.3.5.4.1. South Korea Monkeypox Vaccine and Treatment Market by Product
10.3.5.4.2. South Korea Monkeypox Vaccine and Treatment Market by Gender
10.3.5.4.3. South Korea Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.4.4. South Korea Monkeypox Vaccine and Treatment Market by End-use
10.3.5.5. Australia Monkeypox Vaccine and Treatment Market
10.3.5.5.1. Australia Monkeypox Vaccine and Treatment Market by Product
10.3.5.5.2. Australia Monkeypox Vaccine and Treatment Market by Gender
10.3.5.5.3. Australia Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.5.4. Australia Monkeypox Vaccine and Treatment Market by End-use
10.3.5.6. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market
10.3.5.6.1. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Product
10.3.5.6.2. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Gender
10.3.5.6.3. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by Route of Administration
10.3.5.6.4. Rest of Asia-Pacific Monkeypox Vaccine and Treatment Market by End-use
10.4. RoW
10.4.1. RoW Monkeypox Vaccine and Treatment Market by Product
10.4.2. RoW Monkeypox Vaccine and Treatment Market by Gender
10.4.3. RoW Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.4. RoW Monkeypox Vaccine and Treatment Market by End-use
10.4.5. RoW Monkeypox Vaccine and Treatment Market by Sub-region
10.4.5.1. Latin America Monkeypox Vaccine and Treatment Market
10.4.5.1.1. Latin America Monkeypox Vaccine and Treatment Market by Product
10.4.5.1.2. Latin America Monkeypox Vaccine and Treatment Market by Gender
10.4.5.1.3. Latin America Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.1.4. Latin America Monkeypox Vaccine and Treatment Market by End-use
10.4.5.2. Middle East Monkeypox Vaccine and Treatment Market
10.4.5.2.1. Middle East Monkeypox Vaccine and Treatment Market by Product
10.4.5.2.2. Middle East Monkeypox Vaccine and Treatment Market by Gender
10.4.5.2.3. Middle East Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.2.4. Middle East Monkeypox Vaccine and Treatment Market by End-use
10.4.5.3. Africa Monkeypox Vaccine and Treatment Market
10.4.5.3.1. Africa Monkeypox Vaccine and Treatment Market by Product
10.4.5.3.2. Africa Monkeypox Vaccine and Treatment Market by Gender
10.4.5.3.3. Africa Monkeypox Vaccine and Treatment Market by Route of Administration
10.4.5.3.4. Africa Monkeypox Vaccine and Treatment Market by End-use

Related Topics

Related Reports

Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030] - Product Image

Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030]

  • Report
  • 150 Pages
  • Global
From
2023 U.S. Vaccine Market Report - Product Image

2023 U.S. Vaccine Market Report

  • Report
  • 29 Pages
  • United States
North America Vaccines Market Outlook, 2028 - Product Image

North America Vaccines Market Outlook, 2028

  • Report
  • 101 Pages
  • North America
From
Preventable Vaccines - Global Strategic Business Report - Product Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • 391 Pages
  • Global
From
mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

mRNA Vaccine and Therapeutics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.